Evidence map›Paper›PMID 38794265›Full record

ReviewPharmaceutics2024

Application of Nanomaterial-Based Sonodynamic Therapy in Tumor Therapy.

Nan Yang, Jianmin Li, Shujie Yu, Guoyu Xia, Dingyang Li, Longlong Yuan, Qingluo Wang, Lijun Ding, Zhongxiong Fan, Jinyao Li

Abstract readReview
In one paragraph

Review in Pharmaceutics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Current Research in Drug-Free Cancer Therapies.Bioengineering (Basel, Switzerland) · 2025
    Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Nan YangSchool of Pharmaceutical Sciences, Institute of Materia Medica, College of Life Science and Technology, Xinjiang University, Urumqi 830017, China.
Jianmin LiSchool of Pharmaceutical Sciences, Institute of Materia Medica, College of Life Science and Technology, Xinjiang University, Urumqi 830017, China.
Shujie YuSchool of Pharmaceutical Sciences, Institute of Materia Medica, College of Life Science and Technology, Xinjiang University, Urumqi 830017, China.
Guoyu XiaSchool of Pharmaceutical Sciences, Institute of Materia Medica, College of Life Science and Technology, Xinjiang University, Urumqi 830017, China.
Dingyang LiSchool of Pharmaceutical Sciences, Institute of Materia Medica, College of Life Science and Technology, Xinjiang University, Urumqi 830017, China.
Longlong YuanSchool of Pharmaceutical Sciences, Institute of Materia Medica, College of Life Science and Technology, Xinjiang University, Urumqi 830017, China.
Qingluo WangSchool of Pharmaceutical Sciences, Institute of Materia Medica, College of Life Science and Technology, Xinjiang University, Urumqi 830017, China.
Lijun DingSchool of Pharmaceutical Sciences, Institute of Materia Medica, College of Life Science and Technology, Xinjiang University, Urumqi 830017, China.
Zhongxiong FanSchool of Pharmaceutical Sciences, Institute of Materia Medica, College of Life Science and Technology, Xinjiang University, Urumqi 830017, China.ORCID 0000-0001-5751-9530
Jinyao LiSchool of Pharmaceutical Sciences, Institute of Materia Medica, College of Life Science and Technology, Xinjiang University, Urumqi 830017, China.ORCID 0000-0002-3295-6096

Funding

the Autonomous Region universities' basic research funds, research projects-cultivation projects XJEDU2023P017the Key research and development program in Xinjiang Uygur Autonomous Region 2023B02030, 2023B02030-1, 2022B02058, and 2022B03018-5Tianshan Talent Training Program 2023TSYCLJ0043Xinjiang Uygur Autonomous Region Tianchi Talent Introduction Program-Young Doctor 51052300514
6 · The paper itself

Abstract

Sonodynamic therapy (SDT) has attracted significant attention in recent years as it is an innovative approach to tumor treatment. It involves the utilization of sound waves or ultrasound (US) to activate acoustic sensitizers, enabling targeted drug release for precise tumor treatment. This review aims to provide a comprehensive overview of SDT, encompassing its underlying principles and therapeutic mechanisms, the applications of nanomaterials, and potential synergies with combination therapies. The review begins by introducing the fundamental principle of SDT and delving into the intricate mechanisms through which it facilitates tumor treatment. A detailed analysis is presented, outlining how SDT effectively destroys tumor cells by modulating drug release mechanisms. Subsequently, this review explores the diverse range of nanomaterials utilized in SDT applications and highlights their specific contributions to enhancing treatment outcomes. Furthermore, the potential to combine SDT with other therapeutic modalities such as photothermal therapy (PTT) and chemotherapy is discussed. These combined approaches aim to synergistically improve therapeutic efficacy while mitigating side effects. In conclusion, SDT emerges as a promising frontier in tumor treatment that offers personalized and effective treatment options with the potential to revolutionize patient care. As research progresses, SDT is poised to play a pivotal role in shaping the future landscape of oncology by providing patients with a broader spectrum of efficacious and tailored treatment options.

Indexed as

combined therapynanomaterialsSDT mechanismssonodynamic therapytumor therapy

Identifiers

PMID38794265
PMCPMC11125068

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.